Ashleigh Hull, William Hsieh, William Tieu, Dylan Bartholomeusz, Yanrui Li, & Eva Bezak. (2023). In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer. SpringerOpen.
Chicago Style (17th ed.) CitationAshleigh Hull, William Hsieh, William Tieu, Dylan Bartholomeusz, Yanrui Li, and Eva Bezak. In Vitro Characterisation of [177Lu]Lu-DOTA-C595 as a Novel Radioimmunotherapy for MUC1-CE Positive Pancreatic Cancer. SpringerOpen, 2023.
MLA (9th ed.) CitationAshleigh Hull, et al. In Vitro Characterisation of [177Lu]Lu-DOTA-C595 as a Novel Radioimmunotherapy for MUC1-CE Positive Pancreatic Cancer. SpringerOpen, 2023.
Warning: These citations may not always be 100% accurate.